Bayamban, Baby Boy .
HRN: 26-94-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/12/2025
04/19/2025
INTRAVENOUS
50 Mg IVTT
Every 24 Hours
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes